Moderna Has Chance to Be ‘Vaccine of Choice’: Johns Hopkins

preview_player
Показать описание
Nov.17 -- Johns Hopkins Center for Health Security Senior Scholar Dr. Amesh Adalja discusses vaccine options from Moderna Inc. and Pfizer Inc. and rising hospitalizations in the U.S. He speaks with Bloomberg’s Francine Lacqua on "Bloomberg Surveillance." The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP, the parent company of Bloomberg News.
Рекомендации по теме
Комментарии
Автор

Elon Musk took 4 of the rapid CV tests. At the same place, on the same day, with the same nurse. Two tests came back Positive. Two tests came back Negative. So the reality is the CV tests are as good as Flipping a Coin, to verify CV infection.

dennisg
Автор

Why don't you talk about the 300 people that died at the vaccine during the 40 administration? More people die from the vaccine from the influenza at that time

SabbathSOG
Автор

This is madness. This is something Dr. Frankenstein would not have even touched

SabbathSOG
Автор

Dear obese...
Think of all the dogs you can afford to have rescued from the shelter if you stop being a foodie or just pass away from Covid.

lordvader
Автор

You see the way this guy closes his eyes? To see the way he keeps blinking? That's because he's lying.

SabbathSOG